Developer of central nervous system drugs intended to treat neurological disorders. Gilgamesh Pharmaceuticals provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders.
Market
Healthcare & Wellness
Coinvestors
Route 66,Prime Movers Lab Fund II LP,Prime Movers Labs,NLX,Satori Venture,Ambria,CTR Capital,Negev Capital,Ayuh Ventures,Noetic Fund,Gron Ventures,PsyMed Ventures,Palo Santo